BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5294011)

  • 21. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bladder lavage with Teepol].
    Chatelain C
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):481-3. PubMed ID: 4804425
    [No Abstract]   [Full Text] [Related]  

  • 23. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of spasticity by phenol block.
    Rozin R; Magora F; Robin GC; Magora A
    Isr J Med Sci; 1970; 6(4):555-60. PubMed ID: 5536148
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy and prognosis of bladder papillomatosis].
    Carl P
    MMW Munch Med Wochenschr; 1980 Nov; 122(45):1601-2. PubMed ID: 6779128
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of papillomatosis of the bladder with phenol and glycerin: a clinical and laboratory study.
    Vermooten V; Peters PC; Johnson DE
    J Urol; 1968 May; 99(5):588-92. PubMed ID: 5648556
    [No Abstract]   [Full Text] [Related]  

  • 27. [Superficial bladder carcinoma -- trend of less aggressive therapies].
    Friedrich MG
    Aktuelle Urol; 2006 Jul; 37(4):254-6. PubMed ID: 16955957
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined modality therapy following bladder conservation surgery for bladder cancers.
    Sun X; Hu J; Yang Q
    Chin Med J (Engl); 2002 Oct; 115(10):1548-51. PubMed ID: 12490108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bladder cancer--diagnosis and therapy].
    Schiefelbein F
    Krankenpfl J; 2000; 38(3):64-8. PubMed ID: 10948898
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined radiation and chemotherapy for locally advanced bladder cancer.
    Jakse G; Frommhold H
    Prog Clin Biol Res; 1984; 153():365-72. PubMed ID: 6540880
    [No Abstract]   [Full Text] [Related]  

  • 31. [Concentration profile of repeatedly instilled phenol and glycerin in the canine subarachnoid space (author's transl)].
    Ichiyanagi K; Sakai M; Kato Y
    Masui; 1980 Sep; 29(9):869-71. PubMed ID: 6894172
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatments in invasive bladder cancer].
    Bouchot O; Zerbib M
    Prog Urol; 2003 Dec; 13(6):1415-27. PubMed ID: 15000325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic factors in superficial urothelial bladder tumors treated with different therapeutic modalities].
    Rübben H; Lutzeyer W; Morales M; Mittermayer C; Repges R; Zinng E; Zoedler D; Terhorst B; Lymberopoulos S; Steffens L
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():675-83. PubMed ID: 6537132
    [No Abstract]   [Full Text] [Related]  

  • 34. Bladder preservation after treatment of invasive bladder cancer.
    Lytton B
    N Engl J Med; 1994 Mar; 330(12):867; author reply 867-8. PubMed ID: 8114853
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our experience in treating patients with surface cancer of the bladder].
    Matveev BP; Figurin KM; Romanov VA; Cheban NL
    Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder papilloma: therapeutic and cost effect of outpatient department management.
    Klein FA; Whitmore WF
    Urology; 1981 Sep; 18(3):247-9. PubMed ID: 6792764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The curability of vesical cancer: greater now or then?
    Marshall VF; McCarron JP
    Cancer Res; 1977 Aug; 37(8 Pt 2):2753-5. PubMed ID: 872101
    [No Abstract]   [Full Text] [Related]  

  • 39. [Conservative treatment of vesical papillomatosis using vitamin A acid. Preliminary report].
    Evard JP
    Helv Chir Acta; 1971 Dec; 38(5):541-3. PubMed ID: 5152168
    [No Abstract]   [Full Text] [Related]  

  • 40. [Conservative treatment of recurrent papillomatosis of the urinary bladder with vitamin A acid. Preliminary report].
    Evard JP; Bollag W
    Schweiz Med Wochenschr; 1972 Dec; 102(51):1880-3. PubMed ID: 4567350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.